Wagner Farid Gattaz

Wagner Farid Gattaz's AcademicInfluence.com Rankings

Wagner Farid Gattaz

Biology

#9709

World Rank

#12946

Historical Rank

biology Degrees

Download Badge

Biology

Wagner Farid Gattaz's Degrees

Doctorate Psychiatry University of São Paulo

Why Is Wagner Farid Gattaz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Wagner Farid Gattaz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance (2012) (495)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects (2013) (346)
Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder (2007) (331)
Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial (2011) (328)
Causes and consequences of the gender difference in age at onset of schizophrenia. (1998) (327)
Search for the Causes of Schizophrenia (1987) (314)
Mental Disorders in Megacities: Findings from the São Paulo Megacity Mental Health Survey, Brazil (2012) (312)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia (2005) (301)
Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis (2017) (299)
World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia (2008) (277)
Trial of Electrical Direct‐Current Therapy versus Escitalopram for Depression (2017) (230)
Increased plasma phospholipase-A2 activity in schizophrenic patients: Reduction after neuroleptic therapy (1987) (211)
The Epidemiology of Early Schizophrenia (1994) (196)
Increased serum phospholipase A2 activity in schizophrenia: a replication study. (1990) (195)
Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: A double-blind placebo-controlled study (2005) (195)
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia. (2005) (194)
Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia (2009) (191)
An animal model for the effects of estradiol on dopamine-mediated behavior: Implications for sex differences in schizophrenia (1991) (173)
Increased Serum IL-1β Level in Alzheimer’s Disease and Mild Cognitive Impairment (2009) (168)
Increased platelet phospholipase A2 activity in schizophrenia (1995) (164)
Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. (2009) (161)
Stereologic investigation of the posterior part of the hippocampus in schizophrenia (2009) (149)
Pain perception threshold in major depression (1993) (149)
Cholesterol Modulates the Membrane- Disordering Effects of Beta-Amyloid Peptides in the Hippocampus: Specific Changes in Alzheimer’s Disease (2000) (143)
Reduced cortical folding in schizophrenia: an MRI morphometric study. (2003) (140)
Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia. (2005) (140)
Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis (2009) (140)
Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: A preliminary 4-week study (2011) (130)
Vasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls (1985) (130)
Oxidative stress in early stage Bipolar Disorder and the association with response to lithium. (2014) (129)
Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease (2013) (127)
Diagnosis and biomarkers of predementia in Alzheimer's disease (2010) (126)
Does Lithium Prevent Alzheimer’s Disease? (2012) (125)
Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation (2009) (125)
Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology – a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist (1998) (121)
Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment (2010) (113)
The Bipolar Illness Onset study: research protocol for the BIO cohort study (2017) (111)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation (2015) (109)
Increased phospholipase A2 activity in schizophrenia with absent response to niacin (2003) (108)
Effects of lithium on oxidative stress parameters in healthy subjects. (2011) (107)
Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease (2009) (106)
Altered thalamic membrane phospholipids in schizophrenia: a postmortem study (2004) (106)
Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness☆ (2016) (104)
Insights into Alzheimer disease pathogenesis from studies in transgenic animal models (2011) (103)
Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar non-psychotic refractory depression: a randomized, single-blind study. (2006) (101)
Decreased phospholipase A2 activity in Alzheimer brains (1995) (97)
Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme (2008) (91)
Proteome analysis of schizophrenia brain tissue (2010) (90)
Efficacy and Safety of Transcranial Direct Current Stimulation as an Add-on Treatment for Bipolar Depression: A Randomized Clinical Trial (2017) (90)
Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease. (2011) (89)
BDNF blood levels after electroconvulsive therapy in patients with mood disorders: A systematic review and meta-analysis (2014) (88)
The neuroprotective effect of dental pulp cells in models of Alzheimer’s and Parkinson’s disease (2008) (87)
Diagnostic transitions in mild cognitive impairment subtypes (2009) (84)
Reduced serum levels of adiponectin in elderly patients with major depression. (2012) (83)
Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia (2015) (82)
Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease. (2011) (81)
Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement (2010) (81)
The detection of depression in medical setting: a study with PRIME-MD. (2006) (81)
Mild cognitive impairment: cognitive screening or neuropsychological assessment? (2008) (79)
Influence of the menstrual cycle phase on the therapeutic response in schizophrenia (1994) (77)
Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial (2019) (74)
Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neurotransmission (1991) (71)
Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects. (2015) (71)
Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis (2006) (70)
Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls (1985) (68)
Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder (2013) (68)
Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial (2017) (67)
Polymorphisms in genes involved in neurodevelopment may be associated with altered brain morphology in schizophrenia: Preliminary evidence (2009) (66)
Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease (2005) (65)
Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. (2010) (65)
Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression (2010) (65)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia (2006) (65)
Platelet MAO activity and personality characteristics (1981) (64)
Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease (2008) (64)
Abnormalities in serum concentrations of interleukin-2, interferon-α and interferon-γ in schizophrenia not detected (1992) (63)
Long-term, low-dose lithium treatment does not impair renal function in the elderly: a 2-year randomized, placebo-controlled trial followed by single-blind extension. (2014) (63)
Circulating Glial-derived neurotrophic factor is reduced in late-life depression. (2012) (63)
Reduced serum nerve growth factor in patients with late-life depression. (2012) (62)
Psychiatric aspects of male genital self-mutilation. (1991) (62)
Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory (2005) (61)
Altered Neurotrophin, Neuropeptide, Cytokines and Nitric Oxide Levels in Autism (2012) (61)
Childhood meningitis, brain maturation and the risk of psychosis* (2004) (60)
Decreased S100-beta protein in schizophrenia: preliminary evidence (2000) (60)
CSF monoamine metabolites in schizophrenic patients (1982) (60)
Vocational rehabilitation improves cognition and negative symptoms in schizophrenia (2011) (59)
Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder (2015) (58)
Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia: A Randomized Clinical Trial. (2020) (58)
Neurotensin-like immunoreactivity in cerebrospinal fluid of patients with schizophrenia, depression, anorexia nervosa-bulimia, and premenstrual syndrome. (1989) (57)
To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer’s disease (2009) (57)
The Short Cognitive Performance Test (SKT): a preliminary study of its psychometric properties in Brazil (2005) (57)
Effects of β-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of Aβ1-42 and Aβ1-43 (1998) (57)
Increased platelet membrane lysophosphatidylcholine in schizophrenia (1991) (55)
Depressão e câncer (2009) (55)
Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment. (2010) (55)
Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial (2014) (54)
Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients (1983) (54)
Mild cognitive impairment. Part 1: clinical characteristics and predictors of dementia. (2013) (54)
Abnormal APP processing in platelets of patients with Alzheimer’s disease: correlations with membrane fluidity and cognitive decline (2007) (54)
The value of REM sleep parameters in differentiating Alzheimer's disease from old-age depression and normal aging. (1998) (53)
Platelet phospholipase A2 activity in Alzheimer’s disease and mild cognitive impairment (2004) (53)
Relação entre consumo de drogas e comportamento sexual de estudantes de 2o grau de São Paulo (1999) (52)
Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. (2010) (51)
The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresis. (2007) (50)
Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study (2017) (50)
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia – a short version for primary care (2017) (49)
Cortical NMDA receptor properties and membrane fluidity are altered in Alzheimer's disease. (1996) (49)
Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study (2004) (49)
Bimodal Effect of Lithium Plasma Levels on Hippocampal Glutamate Concentrations in Bipolar II Depression: A Pilot Study (2015) (49)
Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression. (2014) (48)
Childhood meningitis increases the risk for adult schizophrenia (2005) (47)
Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes (2014) (46)
HLA antigens and schizophrenia: A pool of two studies (1981) (46)
Differences in the immune-inflammatory profiles of unipolar and bipolar depression. (2019) (46)
Hypofrontality on topographic EEG in schizophrenia. Correlations with neuropsychological and psychopathological parameters. (1992) (46)
Leukocyte mitochondrial DNA copy number in bipolar disorder (2014) (45)
Antidepressant Efficacy of Adjunctive Aerobic Activity and Associated Biomarkers in Major Depression: A 4-Week, Randomized, Single-Blind, Controlled Clinical Trial (2016) (44)
Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease (2015) (44)
The more information, the more negative stigma towards schizophrenia: Brazilian general population and psychiatrists compared (2013) (44)
Phospholipase A2 and the hypofrontality hypothesis of schizophrenia. (1996) (43)
A Longitudinal (6-week) 3T 1H-MRS Study on the Effects of Lithium Treatment on Anterior Cingulate Cortex Metabolites in Bipolar Depression (2015) (43)
The deleterious effect of ocular artefacts on the quantitative EEG, and a remedy (2005) (43)
Inhibition of phospholipase A2 reduces neurite outgrowth and neuronal viability. (2007) (43)
BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: Results from a factorial, randomized, sham-controlled trial (2014) (42)
Reduced phospholipid breakdown in Alzheimer’s brains: a 31P spectroscopy study (2005) (42)
Low CSF Concentrations of Cyclic GMP in Schizophrenia (1983) (40)
Olanzapine as Alternative Therapy for Patients With Haloperidol-Induced Extrapyramidal Symptoms: Results of a Multicenter, Collaborative Trial in Latin America (2001) (39)
31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism (2002) (39)
Cognitive outcomes of TMS treatment in bipolar depression: Safety data from a randomized controlled trial. (2018) (39)
Hypofrontality on topographic EEG in schizophrenia (2005) (38)
Lithium increases platelet serine-9 phosphorylated GSK-3β levels in drug-free bipolar disorder during depressive episodes. (2015) (38)
Inhibition of phospholipase A2 activity reduces membrane fluidity in rat hippocampus (2005) (38)
Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer’s disease (2012) (38)
Association between BanI genotype and increased phospholipase A2 activity in schizophrenia (2007) (37)
Stigma toward schizophrenia: do all psychiatrists behave the same? Latent profile analysis of a national sample of psychiatrists in Brazil (2013) (37)
Platelet GSK3B activity in patients with late-life depression: Marker of depressive episode severity and cognitive impairment? (2011) (36)
BDNF blood levels after non-invasive brain stimulation interventions in major depressive disorder: A systematic review and meta-analysis (2015) (36)
Low serum levels of 25-hydroxyvitamin D (25-OHD) in children with autism. (2012) (35)
Lack of association between schizophrenia and the phospholipase-A(2) genes cPLA2 and sPLA2. (2001) (35)
Centella asiatica water extract inhibits iPLA2 and cPLA2 activities in rat cerebellum. (2008) (34)
Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): An exploratory analysis (2015) (34)
Low angiotensin-converting enzyme activity (kininase II) in cerebrospinal fluid of schizophrenics. (1984) (33)
Differential roles of phospholipases A2 in neuronal death and neurogenesis: Implications for Alzheimer disease (2010) (33)
Lithium Decreases Plasma Adiponectin Levels in Bipolar Depression (2014) (32)
Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms (2017) (32)
The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer’s disease (2007) (32)
COMT Met (158) modulates facial emotion recognition in bipolar I disorder mood episodes. (2012) (32)
Plasma cortisol in first episode drug-naïve mania: differential levels in euphoric versus irritable mood. (2012) (32)
Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression (2018) (31)
Poverty, low education, and the expression of psychotic-like experiences in the general population of São Paulo, Brazil (2017) (31)
Inhibition of platelet phospholipase A2 activity by catuaba extract suggests antiinﬂammatory properties (2004) (31)
Requirement of hippocampal phospholipase A2 activity for long-term memory retrieval in rats (2007) (30)
Platelet phospholipase A(2) activity in Alzheimer's disease and mild cognitive impairment. (2004) (29)
Multidisciplinary rehabilitation program: effects of a multimodal intervention for patients with Alzheimer’s disease and cognitive impairment without dementia (2015) (29)
Glutamate in schizophrenics and healthy controls (2004) (29)
Allelic association analysis of phospholipase A2 genes with schizophrenia (2004) (28)
Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia (2001) (28)
Modulation of phospholipase A2 activity in primary cultures of rat cortical neurons (2005) (28)
Body Mass Index Increase, Serum Leptin, Adiponectin, Neuropeptide Y and Lipid Levels during Treatment with Olanzapine and Haloperidol (2011) (28)
Rightward cerebral asymmetry in subtypes of schizophrenia according to Leonhard's classification and to DSM-IV: a structural MRI study (2003) (28)
Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer’s disease patients (2018) (27)
REM sleep parameters in the discrimination of probable Alzheimer's disease from old-age depression (1993) (27)
Home-Based Psychiatric Outpatient Care Through Videoconferencing for Depression: A Randomized Controlled Follow-Up Trial (2016) (27)
Long-term lithium treatment increases intracellular and extracellular brain-derived neurotrophic factor (BDNF) in cortical and hippocampal neurons at subtherapeutic concentrations. (2016) (27)
CT scans and neuroleptic response in schizophrenia: A multidimensional approach (1988) (27)
Cognitive training increases platelet PLA2 activity in healthy elderly subjects. (2008) (27)
Effects of haloperidol on somatostatin-like immuno-reactivity in the CSF of schizophrenic patients (1986) (27)
Omega-3 consumption and sudden cardiac death in schizophrenia. (2009) (27)
Cognitive impairment in late‐life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid (2016) (26)
Elevated neurotrophin-3 and neurotrophin 4/5 levels in unmedicated bipolar depression and the effects of lithium (2015) (26)
Inhibition of cPLA2 and sPLA2 Activities in Primary Cultures of Rat Cortical Neurons by Centella asiatica Water Extract (2012) (26)
Formal Thought Disorder and language impairment in schizophrenia. (2012) (26)
Antidepressant effects of tDCS are associated with prefrontal gray matter volumes at baseline: Evidence from the ELECT-TDCS trial (2019) (25)
O estigma atribuído pelos psiquiatras aos indivíduos com esquizofrenia (2011) (25)
Public stigmatization of different mental disorders: a comprehensive attitude survey (2012) (25)
Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein (2011) (25)
Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype (2013) (25)
Ansiedade na performance musical: tradução, adaptação e validação do Kenny Music Performance Anxiety Inventory (K-MPAI) para a língua portuguesa (2011) (24)
Transcranial direct current stimulation (tDCS) for preventing major depressive disorder relapse: Results of a 6‐month follow‐up (2019) (24)
Moclobemide versus fluoxetine in the treatment of inpatients with major depression. (1995) (24)
Effects of beta-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of A beta 1-42 and A beta 1-43. (1998) (24)
Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism (2011) (24)
Association of a new polymorphism in ALOX12 gene with bipolar disorder (2003) (24)
Increased PLA2 activity in the hippocampus of patients with temporal lobe epilepsy and psychosis. (2011) (23)
Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment (2015) (23)
Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease. (2013) (23)
Melatonin immunoreactivity in cerebrospinal fluid of schizophrenic patients and healthy controls (1984) (23)
Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats (2005) (23)
Diretrizes da Federação Mundial das Sociedades de Psiquiatria Biológica para o tratamento biológico da esquizofrenia. Parte 2: tratamento de longo prazo (2006) (23)
Language impairment in euthymic, elderly patients with bipolar disorder but no dementia (2008) (23)
Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study (2014) (23)
Long-term decrease in immediate early gene expression after electroconvulsive seizures (2013) (22)
Outcomes for Latin American Versus White Patients Suffering From Acute Mania in a Randomized, Double-Blind Trial Comparing Olanzapine and Haloperidol (2007) (22)
Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial. (2015) (22)
Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy (2015) (22)
Inhibition of phospholipase A2 in rat brain modifies different membrane fluidity parameters in opposite ways (2011) (22)
[Cranial computed tomography in schizophrenia research]. (1981) (22)
Childhood Adversity and Adult Onset of Hypertension and Heart Disease in São Paulo, Brazil (2013) (22)
Increased cell proliferation in the rat anterior cingulate cortex following neonatal hypoxia: relevance to schizophrenia (2012) (22)
Lithium increases nitric oxide levels in subjects with bipolar disorder during depressive episodes. (2014) (21)
Conjugated linoleic acid-enriched butter improved memory and up-regulated phospholipase A2 encoding-genes in rat brain tissue (2015) (21)
O estigma da esquizofrenia na mídia: um levantamento de notícias publicadas em veículos brasileiros de grande circulação (2012) (21)
Patterns of stigma toward schizophrenia among the general population: A latent profile analysis (2014) (21)
Basal ganglia abnormalities in tardive dyskinesia (1994) (21)
Olanzapine versus flupenthixol in the treatment of inpatients with schizophrenia: a randomized double-blind trial. (2004) (21)
Cognitive-linguistic deficits in euthymic elderly patients with bipolar disorder. (2013) (20)
Differential effects of trimipramine and fluoxetine on sleep in geriatric depression. (2001) (20)
Early improvement with lithium in classic mania and its association with later response. (2013) (20)
Analysis of coding-polymorphisms in NOTCH-related genes reveals NUMBL poly-glutamine repeat to be associated with schizophrenia in Brazilian and Danish subjects (2006) (20)
The evaluation of 4-hydroxy-3-methoxyphenylglycol sulfate as a possible marker of central norepinephrine turnover. Studies in healthy volunteers and depressed patients. (1988) (20)
Erratum: The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresis (Briefings in Functional Genomics and Proteomics (2007) vol. 6 (70-75)) (2009) (19)
Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression. (2012) (19)
Increased brain membrane fluidity in schizophrenia. (2011) (19)
Does BDNF genotype influence creative output in bipolar I manic patients? (2012) (19)
Precision non-implantable neuromodulation therapies: a perspective for the depressed brain (2020) (19)
Lithium Distinctly Modulates the Secretion of Pro- and Anti- Inflammatory Interleukins in Co-Cultures of Neurons and Glial Cells at Therapeutic and Sub-Therapeutic Concentrations. (2016) (19)
Clinical patterns differentially predict response to transcranial direct current stimulation (tDCS) and escitalopram in major depression: A machine learning analysis of the ELECT-TDCS study. (2020) (19)
Leukocyte telomerase activity and antidepressant efficacy in bipolar disorder (2014) (18)
APOE Genotype and Alzheimer´s Disease (2000) (18)
Kynurenine is correlated with IL-1β in plasma of schizophrenia patients (2018) (18)
Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice. (2018) (18)
Abnormalities in serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia not detected. (1992) (18)
Nogo CAA 3′UTR Insertion polymorphism is not associated with Schizophrenia nor with bipolar disorder (2005) (18)
Low platelet MAO activity and schizophrenia: sex differences (1981) (17)
HLA ANTIGENS AND SCHIZOPHRENIA (1980) (17)
USE OF PSYCHOACTIVE SUBSTANCES AND SEXUAL RISK BEHAVIOR IN ADOLESCENTS (2002) (17)
Aripiprazole for Patients with Schizophrenia and Schizoaffective Disorder: An Open-Label, Randomized, Study Versus Haloperidol (2009) (17)
Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients (2015) (17)
Recognition of Depressive Symptoms by Physicians (2009) (17)
Lower doses of sublingual Zolpidem are more effective than oral Zolpidem to anticipate sleep onset in healthy volunteers. (2013) (17)
Multifocal slow potential generation revealed by high-resolution EEG and current density reconstruction. (2002) (17)
Inhibition of phospholipase A2 increases tau phosphorylation at Ser214 in embryonic rat hippocampal neurons. (2010) (16)
Long-Term Lithium Treatment Increases cPLA2 and iPLA2 Activity in Cultured Cortical and Hippocampal Neurons (2015) (16)
HLA-B27 as a possible genetic marker of psychoticism (1981) (16)
Hippocampal serotonin depletion is related to the presence of generalized tonic–clonic seizures, but not to psychiatric disorders in patients with temporal lobe epilepsy (2015) (16)
Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study. (2014) (16)
Hearing spirits? Religiosity in individuals at risk for psychosis—Results from the Brazilian SSAPP cohort (2019) (16)
Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls (2002) (15)
Fluoxetine versus trimipramine in the treatment of depression in geriatric patients. (2005) (15)
Plasma lipids metabolism in mild cognitive impairment and Alzheimer’s disease (2019) (15)
Violencia e doenca mental: fato ou ficcao? (1999) (15)
Cardiovascular effects of fluvoxamine and maprotiline in depressed patients (2005) (15)
Loss of interest, depressed mood and impact on the quality of life: Cross-sectional survey (2011) (15)
Mental healthcare in South America with a focus on Brazil: past, present, and future (2016) (15)
Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease (1986) (14)
Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia (2005) (14)
Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer’s disease patients (2018) (14)
A possible association between HLA B-27 and vulnerability to schizophrenia (1985) (14)
Haloperidol increases the cerebrospinal fluid concentrations of cyclic GMP in schizophrenic patients. (1984) (14)
SHORT COMMUNICATION: Apolipoprotein E genotype and Cognition in Bipolar Disorder (2010) (14)
Phospholipase A2 activity in rat embryonic brain and in primary cultures of cortical neurons (2002) (14)
Uso de drogas entre estudantes de uma escola pública de São Paulo (2001) (14)
Diurnal variability of orofacial dyskinetic movements. (1999) (13)
Alterations of Brain Membranes in Schizophrenia: Impact of Phospholipase A2 (2012) (13)
Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial (2019) (13)
Acute and subchronic effects of low-dose bromocriptine in haloperidol-treated schizophrenics (1989) (13)
Disclosing the diagnosis of schizophrenia: A pilot study of the ‘Coming Out Proud’ intervention (2019) (13)
Complex slow potential generators in a simplified attention paradigm. (2006) (13)
Computer Tomographic Studies in Schizophrenia (1990) (13)
Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study (2014) (13)
Stereological investigation of the CA1 pyramidal cell layer in untreated and lithium-treated 3xTg-AD and wild-type mice. (2017) (13)
Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania. (2012) (13)
The generators of slow potentials obtained during verbal, pictorial and spatial tasks. (2003) (13)
Regulation of leukocyte tricarboxylic acid cycle in drug-naïve Bipolar Disorder (2015) (12)
Bromocriptine in the treatment of neuroleptic-resistant schizophrenia (1986) (12)
Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer’s disease patients (2019) (12)
Proteome analysis of human dorsolateral prefrontal cortex using shotgun mass spectrometry. (2008) (12)
Intracerebral injection of phospholipase A2 inhibits dopamine-mediated behavior in rats: Possible implications for schizophrenia (2005) (12)
Münchhausen syndrome: psychopathology and management. (1990) (12)
Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets. (2016) (11)
DNA polymorphisms as tools for spinal cord injury research (2009) (11)
Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer’s disease: a pilot study (2019) (11)
Alterations of brain membranes in schizophrenia: impact of phospholipase A(2). (2012) (11)
Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission. (2015) (11)
Benefits of psychodynamic group therapy on depression, burden and quality of life of family caregivers to Alzheimer’s disease patients (2015) (11)
A psychiatric unit in a general hospital in Brazil: predictors of length of stay (1992) (11)
Guidelines for biological Treatment of Schizophrenia, : Part 1: Acute Treatment of Schizophrenia and Part 2: Long-term Treatment of Schizophrenia (2005) (11)
Cytochrome P450 genotypes are not associated with refractoriness to antipsychotic treatment (2015) (11)
Alpha-tocopherol in the treatment of tardive dyskinesia (1992) (11)
Widespread electrical cortical dysfunction in schizophrenia (2004) (11)
Structural Brain Abnormalities in Schizophrenia: An Integrative Model (1987) (11)
Lithium activates brain phospholipase A2 and improves memory in rats: implications for Alzheimer’s disease (2016) (10)
Lower phosphorylated glycogen synthase kinase-3B levels in platelets of patients with schizophrenia: increment by olanzapine treatment (2015) (10)
Pioneering ambient mass spectrometry imaging in psychiatry: Potential for new insights into schizophrenia (2016) (10)
Quantification of tryptophan in plasma by high performance liquid chromatography (2012) (10)
The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects (2015) (10)
Cognitive changes after tDCS and escitalopram treatment in major depressive disorder: Results from the placebo-controlled ELECT-TDCS trial. (2019) (10)
Advances in Schizophrenia Research 2009 (2010) (10)
Phospholipase A2 in Schizophrenia (1992) (10)
Exploring the knowledge contained in neuroimages: Statistical discriminant analysis and automatic segmentation of the most significant changes (2010) (9)
Reduced activities of phospholipases A2 in platelets of drug-naïve bipolar disorder patients. (2015) (9)
Increased CSF cortisol levels after neuroleptic treatment in schizophrenia (1985) (9)
Biochemical and Neuropathological Indices for the Aetiology of Schizophrenia (1987) (9)
Oestrogen-A Protective Factor in Schizophrenia? (2006) (9)
Glycogen synthase kinase‐3β in patients with bipolar I disorder: results from a prospective study (2016) (9)
A radioenzymatic assay to identify three groups of phospholipase A(2) in platelets. (2012) (9)
Balance of the Century (1999) (8)
Intracerebroventricular injection of phospholipase A2 inhibits apomorphine-induced locomotion in rats (1995) (8)
ARTHROPATHIES AND SCHIZOPHRENIA (1980) (8)
Relative bioavailability of two oral formulations of risperidone 2 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Brazilian volunteers. (2010) (8)
Platelet MAO activity in major psychoses. (1983) (8)
Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes (2016) (8)
Magnesium and calcium in the CSF of schizophrenic patients and healthy controls: correlations with cyclic GMP. (1983) (8)
[Münchhausen syndrome: diagnosis and management]. (2003) (7)
BDNF blood levels after electroconvulsive therapy in patients with mood disorders: An updated systematic review and meta-analysis (2022) (7)
Correlation between platelet and brain PLA(2) activity. (2013) (7)
Acute hormonal changes after IV citalopram and treatment response in OCD (2007) (7)
Assessment of tardive dyskinesia by means of digital image processing (2005) (7)
The schizophrenia stigma and mass media: a search for news published by wide circulation media in Brazil (2017) (7)
Thalamic nuclear abnormalities as a contributory factor in sudden cardiac deaths among patients with schizophrenia (2010) (7)
Effects of tDCS on neuroplasticity and inflammatory biomarkers in bipolar depression: Results from a sham-controlled study (2020) (7)
5‐hydroxytryptamine1A receptor density in the hippocampus of patients with temporal lobe epilepsy is associated with disease duration (2017) (7)
Auditory evoked potentials in schizophrenic patients before and during neuroleptic treatment (1993) (7)
Conditioning training and retrieval increase phospholipase A2 activity in the cerebral cortex of rats (2008) (7)
Estradiol attenuates dopamine-mediated behavior in rats. Implications for sex differences in schizophrenia (1992) (7)
Antipsychotic drugs decrease iPLA2 gene expression in schizophrenia (2013) (6)
Relação entre consumo de drogas e comportamento sexual de estudantes de 2 o grau de São Paulo* Relationship between drug consumption and sexual behavior among high school students of São Paulo (1999) (6)
MK-801 induced stereotypies in rats are decreased by haloperidol and increased by diazepam (2005) (6)
Cortical surface abnormalities are different depending on the stage of schizophrenia: A cross-sectional vertexwise mega-analysis of thickness, area and gyrification (2021) (6)
Auditory evoked potentials in schizophrenic patients before and during neuroleptic treatment. Relationship to psychopathological state (1992) (6)
Oral tardive dyskinesia: validation of a measuring device using digital image processing (2005) (6)
Digital movement analysis, a new objective method of measuring tardive dyskinesia and drug-induced parkinsonian tremor: acceptability, reliability and validity (2005) (6)
[Estradiol inhibits dopamine mediated behavior in rats--an animal model of sex-specific differences in schizophrenia]. (1992) (6)
Fatty acid and phospholipase A2 plasma levels in children with autism. (2013) (6)
[Accelerated breakdown of membrane phospholipids in schizophrenia--implications for the hypofrontality hypothesis]. (1994) (6)
[Possible involvement of phospholipase A2 in the pathogenesis of schizophrenia]. (1990) (6)
Nanotubos de carbono aplicados às neurociências: perspectivas e desafios (2011) (6)
Cognitive outcomes of the bipolar depression electrical treatment trial (BETTER): a randomized, double-blind, sham-controlled study (2020) (5)
Algumas recomendações para estudos com placebo (2000) (5)
Glycogen Synthase Kinase-3β: Variation over Time and the Possible Association with Mood and Cognition in Healthy Individuals (2016) (5)
BDNF Val66Met polymorphism is not related with temporal lobe epilepsy caused by hippocampal sclerosis in Brazilian population (2018) (5)
Topographic abnormality of slow cortical potentials in schizophrenia. (2004) (5)
EEG alpha peak frequency analysis during memorizing of figures in patients with mild cognitive impairment. (2009) (5)
Diagnosis and biomarkers of predementia in (2010) (5)
DONEPEZIL MODULATES ADAM10 AND BACE1 EXPRESSION IN PLATELETS OF ALZHEIMER'S DISEASE PATIENTS (2016) (5)
Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study (2014) (5)
Influência de mecanismos colinérgicos nos processos neurodegenerativos relacionados à formação de amilóide e à fosforilação da proteína tau (2000) (4)
Phenylethylamine and monoamine metabolites in CSF of schizophrenics: Effects of neuroleptic treatment (2005) (4)
Reduced Annexin A3 in schizophrenia (2019) (4)
Accelerated Breakdown of Platelet Membrane Phospholipids in Schizophrenia (1992) (4)
Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls (1982) (4)
Cerebrospinal fluid concentrations of free GABA in schizophrenia: No changes after haloperidol treatment (2005) (4)
[Biologic artifacts in quantitative EEG]. (2006) (4)
[Antipsychotics and phospholipid metabolism in schizophrenia]. (2001) (4)
Synergistic and additive effects of enriched environment and lithium on the generation of new cells in adult mouse hippocampus (2014) (4)
Do Human Erythrocyte Membranes Contain Muscarinic Cholinergic Receptors (1986) (4)
Prefrontal resting-state connectivity and antidepressant response: no associations in the ELECT-TDCS trial (2020) (4)
Cognitive outcomes after tDCS in schizophrenia patients with prominent negative symptoms: Results from the placebo-controlled STARTS trial (2021) (4)
The effect of rivastigmine on sleep in elderly healthy subjects [Experimental Gerontology 35 (2000) 243–249] (2000) (4)
Prevalência de depressão em mulheres idosas com fratura de quadril (2009) (3)
Is schizophrenia disappearing? (1991) (3)
Glycogen synthase kinase-3β activity and cognitive functioning in patients with bipolar I disorder (2018) (3)
Higher transcription alleles of the MAOA-uVNTR polymorphism are associated with higher seizure frequency in temporal lobe epilepsy (2019) (3)
Estudos de neuroimagem na classificacao de Leonhard (2002) (3)
Plasmatic endocannabinoids are decreased in subjects with ultra‐high risk of psychosis (2021) (3)
Plasma metabolites in first episode psychoses (2019) (3)
[Relevance of metabolism of membrane phospholipids for Alzheimer dementia]. (1996) (3)
Low platelet PLA2 activity predicts conversion from mild cognitive impairment to Alzheimer's disease: A 4-year follow-up study (2013) (3)
Chronic inhibition of brain phospholipase A2 in adult rats impairs the survival of newborn mature neurons in the hippocampus (2015) (3)
Phospholipase A2 and hypofrontality in schizophrenia (1996) (3)
Lithium and neuroprotection: new potential uses in psychiatry (2007) (3)
Influence of migration on the thought process of individuals at ultra-high risk for psychosis (2020) (3)
Exacerbation of psychosis risk during the COVID-19 pandemic: The disproportionate impact on the lower income population (2021) (3)
Estabilidade intra-individual dos parâmetros obtidos pela espectroscopia de fósforo do encéfalo (1999) (3)
O uso do lítio em idosos: evidências de sua ação neuroprotetora (2002) (3)
Relationship Between Symptomatic Dimensions and Global Functioning of Non-Help-Seeking Individuals at Risk for Psychosis. (2020) (3)
Low-dose pergolide in the treatment of tardive dyskinesia (TD): A double-blind, placebo-controlled randomized cross-over trial (1999) (2)
Tardive dyskinesia: Recognition and quantification by means of digital image processing (1992) (2)
Childhood meningitis and adult schizophrenia (2004) (2)
Cold weather and risk of sudden cardiac death in schizophrenia: finding a new Achilles' heel? (2008) (2)
Motion energy analysis during speech tasks in medication-naïve individuals with at-risk mental states for psychosis (2022) (2)
Schizophrenia TreAtment with electRic Transcranial Stimulation (STARTS): design, rationale and objectives of a randomized, double-blinded, sham-controlled trial. (2019) (2)
Temporal stability of auditory evoked potentials at different stimulation rates. (1994) (2)
An early psychosis research program in São Paulo, Brazil: Organization and implementation (2008) (2)
HLA-Antigens, Schizophrenia and Brain Atrophy (1980) (2)
[Tardive dyskinesia: pergolid, a possible therapeutic option]. (2003) (2)
CSF Studies in Schizophrenia: A Multidimensional Approach (1985) (2)
Does vitamin E prevent tardive dyskinesia? (1995) (2)
Effects of the menstrual cycle on therapeutic response in schizophrenic patients (1992) (2)
The HLA system and schizophrenia (1980) (2)
A double blind placebo controlled study of conjugated estrogens added to haloperidol in patients with schizophrenia (2001) (2)
Increased PLA2 activity in individuals at ultra-high risk for psychosis (2021) (2)
[The isolated olfactory hallucinosis and the olfactory hallucinations in the endogenous psychoses (author's transl)]. (1982) (2)
HLA, Schizophrenien und Arthropathien (1981) (2)
Increased phospholipase A2 activity in schizophrenia (1992) (2)
Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis (2017) (2)
COX-2 pathway is upregulated in ultra-high risk individuals for psychosis (2021) (2)
The role of lithium treatment on comorbid anxiety symptoms in patients with bipolar depression. (2022) (2)
T203. ILLICIT DRUGS USE AND ULTRA-HIGH RISK (UHR) FOR PSYCHOSIS STATUS IN A LATIN-AMERICAN SAMPLE (2018) (2)
Tomografia cerebral computadorizada e esquizofrenia: revisão crítica da literatura (1988) (2)
Functional impairment prevalence in Brazilian frailty elderly (2011) (2)
Cholinesterase inhibitors increase iPLA2 activity in platelets of patients with Alzheimer's disease (2012) (1)
Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment (2004) (1)
Lithium Affects Cortical and Subcortical Volume in Bipolar Depressed Patients (2022) (1)
P3-229: GAB2, GSTP1 and GAPDH polymorphisms and their potential role in late-onset Alzheimer's disease (2008) (1)
Increased lysophosphatidylcholine content in platelet membrane of schizophrenics (1992) (1)
Vitamin E Attenuates the Development of Neuroleptic‐Induced Dopaminergic Hypersensitivity in Rats: Implications for Tardive Dyskinesia (1992) (1)
Reversal of microstructural white matter changes in drug-naive patients with first-episode psychosis after antipsychotic treatment (2014) (1)
Correction: The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects (2015) (1)
PLATELET APP RATIO IN AD PATIENTS TREATED WITH DONEPEZIL (2014) (1)
Erratum to Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia [Journal of Psychiatric Research (2009); 43(11): 978–86] (2011) (1)
P0341 - Memantine induces expression of PLA2 genes in rat brain: Possible implications for reverse learning and memory of Alzheimer's disease patients (2008) (1)
Diretrizes da Federação Mundial das Sociedades de Psiquiatria Biológica para o tratamento biológico da esquizofrenia. Parte 2: tratamento de longo prazo World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia. Part 2: long-term treatment (2006) (1)
LIPID METABOLITE PLASMA LEVELS AS BIOMARKERS OF EARLY-ONSET ALZHEIMER DISEASE (2017) (1)
A criminalização do doente mental: como fazer e como evitar (1999) (1)
Classificacao das psicoses endogenas de Karl Leonhard (1998) (1)
SPERMINE AS A POTENTIAL PERIPHERAL BIOMARKER OF MILD COGNITIVE IMPAIRMENT AND ALZHEIMER’S DISEASE (2017) (1)
Long-term sertraline treatment increases expression and phosphorilation of glycogen synthase kinase-3B in platelets of patients with late-life major depression (2012) (1)
S193. EFFICACY AND SAFETY OF TRANSCRANIAL DIRECT CURRENT STIMULATION FOR TREATING NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: THE FOLLOW-UP PHASE (2020) (1)
Polymorfism Of CYP2C9 And 3A5 and carbamazepine hypersensitivity reactions in Brazilian subjects (2014) (1)
Activity of phospholipase A2 (PLA2) subtypes in rat brain is altered by feeding conjugated linoleic acid (CLA) and linseed oil (2009) (1)
Alzheimer’s Disease-related Biomarkers in Aging Adults with Down Syndrome: Systematic Review (2019) (1)
Addressing Mood Disorder Diagnosis' Stigma With an Honest, Open, Proud (HOP)-Based Intervention: A Randomized Controlled Trial (2021) (1)
What Does Proteomics Tell Us About Schizophrenia (2011) (1)
[The histocompatibility system in schizophrenia]. (1982) (1)
Childhood maltreatment in individuals at risk of psychosis: Results from the Brazilian SSAPP cohort (2020) (1)
Lítio crônico potencializa a sobrevivência de novas células induzida por enriquecimento ambiental no hipocampo de camundongos adultos* Chronic lithium potentiates enrichment-induced survival of new cells in the hippocampus of adult mice (2013) (1)
Inhibition of phospholipase A2 modulates glycogen synthase kinase (GSK) activity and Tau phosphorylation in primary cultures of cortical and hippocampal neurons (2009) (1)
ESTRADIOL ATTENUATES DOPAMINE-MEDIATED BEHAVIOR IN RATS: IMPLICATIONS FOR SEX DIFFERENCES IN SCHIZOPHRENIA (1992) (1)
[Cerebral computed tomography and schizophrenia: a critical review of the literature]. (1988) (1)
Alprazolam response in major depression: relationship with urinary levels of MHPG-sulfate. (1988) (1)
T204. Treatment of Negative Symptoms of Schizophrenia With tDCS (Transcranial Direct Current Stimulation): A Randomized, Sham-Controlled, Double-Blinded Clinical Trial (2018) (1)
Urinary MHPG-sulfate and urinary MHPG-glucuronide, two possible markers of the central or peripheral norepinephrine metabolism in man. The effect of alprazolam treatment. (1988) (1)
Profi les of functional defi cits in mild cognitive impairment and dementia: benefi ts from objective measurement (2010) (1)
Prevalence of cognitive impairment in Brazilian frailty elderly (2011) (1)
Environmental risk factors of psychosis (2002) (1)
Administrative influences on psychiatric diagnosis (1988) (1)
Antipsychotics preserve telomere length in peripheral blood mononuclear cells after acute oxidative stress injury (2021) (1)
A randomized clinical trial of home-based telepsychiatric outpatient care via videoconferencing: design, methodology, and implementation (2015) (1)
Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes (2014) (1)
Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease (2012) (1)
Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex (2004) (1)
Serum nerve growth factor (NGF) level is reduced in mild cognitive impairment and Alzheimer's disease (2011) (1)
Repetitive Transcranial Magnetic Stimulation in Augmentation of Antidepressant Drugs (2007) (1)
Genetic and Proteomic Studies in Schizophrenia (2010) (1)
Latency increase of auditory-evoked potential component N1 predicts poor neuroleptic response in schizophrenic patients. (1994) (1)
Network Meta-analysis in Mental Health Treatment Research-Reply. (2017) (0)
Front & Back Matter (2016) (0)
39-105 Increased membrane phospholipid reakdown in schizoiphrenic patients during neuroleptic treatment (1997) (0)
Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment Preditores clínicos e biológicos da evolução para doença de Alzheimer em pacientes com comprometimento cognitivo leve amnéstico (2009) (0)
Response (1987) (0)
Cholinergic drug downregulates annexin A3 in platelets of Alzheimer’s Disease patients (2022) (0)
Alpha-tocopherol attenuates the development of neuroleptic-induced dopaminergic hypersensitivity in rats. Implications for tardive dyskinesia (1992) (0)
Front & Back Matter (2015) (0)
P.5.b.001 The role of hippocampal phospholipase A2 in memory retrieval in rats (2006) (0)
Phospholipase A 2 hemmt die dopaminerge Neurotransmission bei Ratten in vivo (1996) (0)
Cognitive Patterns and Conversion in a Representative Sample of Individuals at Risk for Psychosis (2021) (0)
Efeito da adição do estrógeno conjugado em pacientes esquizofrênicas em tratamento com haloperidol: estudo duplo-cego (2001) (0)
Novo estabelecimento de ensaios radioreceptores D1 e D2 em substância cinzenta de cérebro humano (2003) (0)
Contents Vol. 28, 2009 (2010) (0)
LITHIUM TREATMENT PREVENTS AMYLOID TOXICITY AND MIR-489 DOWN-REGULATION IN AN ALZHEIMER’S DISEASE IN VITRO MODEL (2016) (0)
Assessment of association cortex activity by high-resolution EEG and current density reconstruction (2000) (0)
Acknowledgement to referees (2008) (0)
REM Sleep Criteria - Putative Markers for Distinction of Alzheimer's Disease and Major Depression (1995) (0)
P1-366: Glycogen synthase kinase activity in platelets of patients with Alzheimer's disease, mild cognitive impairment and controls (2008) (0)
Proteomic Characterization of the Brain and Cerebrospinal Fluid of Schizophrenia Patients (2014) (0)
Association between anxiety, depression and cognitive dysfunction in patients with multiple sclerosis (0)
Childhood abuse and family violence in relation to adult onset of hypertension and heart disease in São Paulo, Brazil (2013) (0)
P3-067 Brazilian version of the Short Cognitive Performance Test (SKT) - psychometric properties and diagnostic accuracy in Alzheimer’s disease (AD) and mild cognitive impairment (MCI) (2006) (0)
DONEPEZIL EFFECTS ON CHOLESTEROL AND OXYESTEROLS PLASMA LEVELS OF ALZHEIMER’S DISEASE PATIENTS (2017) (0)
Leonhard´s classification of Schizophrenias and MRI brain abnormalities: preliminary results (1999) (0)
Auditory Evoked Potentials and Rrediction of Short‐Term Neuroleptic Response in Schizophrenia (1992) (0)
Subject Index Vol. 28, 2009 (2010) (0)
Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease (2015) (0)
Pattern of proteolytic processing of Amyloid Precursor Protein in Down syndrome (2021) (0)
Testes de rastreio cognitive vs. bateria neuropsicológica na identificação do compromentimento cognitvo leve e seus subtipos (2008) (0)
P2-391: Lithium inhibits GSK3β transcription in hippocampal neurons and human leukocytes (2008) (0)
Alzheimer's disease: Donepezil effects on cholesterol and oxysterol plasma levels (2020) (0)
Decision tree-based classification as a support to diagnosis in the Alzheimer’s disease continuum using cerebrospinal fluid biomarkers: insights from automated analysis (2022) (0)
Front & Back Matter (2015) (0)
P3-035: Bipolar disorder in old age: Prospective evaluation of cognitive functions (2008) (0)
Platelet APP levels from subjects with Alzheimer’s disease and mild cognitive impairment (2020) (0)
Long-term lithium treatment for patients with mild cognitive impairment: Benefits on cognition and evidence of disease modification (2010) (0)
P3-349: Cognitive training increases platelet PLA2 activity in healthy elderly subjects (2008) (0)
Brain-derived neurotrophic factor serum level is reduced in mild cognitive impairment and Alzheimer's disease (2009) (0)
Activity of PLA2 Forms in Primary Neuronal Cultures (2007) (0)
Corrigendum to cytochrome P450 genotypes are not associated with refractoriness to antipsychotic treatment [Schizophr. Res. 168 (2015) 587–588] (2016) (0)
Inhibition of phospholipase A2 modulates glycogen synthase kinase (GSK) activity and Tau phosphorylation in primary cultures of cortical and hippocampal neurons (2009) (0)
Chronic inhibition of brain phospholipase A2 in rats as a model to investigate Alzheimer-related alterations: a preliminary study (2007) (0)
The Bipolar Illness Onset study (2017) (0)
A Longitudinal MRI-study of the Effects of Lithium on Cortical Thickness and Brain Volume and its association with Clinical Response in Bipolar Disorder (2019) (0)
Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial (2013) (0)
S109. Antidepressant Effects of TDCS are Associated With Prefrontal Grey Matter Volumes at Baseline: Evidence From the ELECT-tDCS Trial (2019) (0)
Lithium increases cortical and subcortical volumes in subjects with bipolar disorder (2022) (0)
Genetic polymorphisms of the serotonin transporter are not related with depression in temporal lobe epilepsy caused by hippocampal sclerosis (2021) (0)
Editorial announcement regarding new impact factor and title change (2014) (0)
A new editorial board for new challenges (2017) (0)
PROTEOME ANALYSES OF POST-MORTEM BRAIN TISSUE FROM PATIENTS WITH SCHIZOPHRENIA SUGGEST DYSFUNCTION OF OLIGODENDROCYTES AND ASTROCYTES AND POTENTIAL BIOMARKER CANDIDATES? (2012) (0)
F42. COGNITIVE PATTERNS ASSOCIATED WITH CHILDHOOD TRAUMA AND RISK FOR PSYCHOSIS IN A POPULATIONAL SAMPLE–A LATENT PROFILE ANALYSIS (2019) (0)
Shotgun proteome analysis of schizophrenia brain tissue (2008) (0)
Mild cognitive impairment: cognitive screening or neuropsychological assessment? Comprometimento cognitivo leve: rastreio cognitivo ou avaliação neuropsicológica? (2008) (0)
SU21 INTEGRATED ANALYSIS OF MICROARRAY AND PROTEOMICS DATA BY HIPPOCAMPAL RAT NEURONS AND HUMAN IPS NEURONS TREATED WITH DIFFERENT DOSES OF LITHIUM (2019) (0)
Cytokines analysis in therapeutic and sub-therapeutic lithium-treated primary neuron and glia co-culture (2013) (0)
Meeting report: The Schizophrenia International Research Society (SIRS) South America Conference (August 5–7, 2011) (2012) (0)
S131. PERCEPTUAL ABNORMALITIES AND RELIGIOSITY IN ULTRA HIGH-RISK FOR PSYCHOSIS (UHR) INDIVIDUALS IN A LATIN AMERICAN POPULATIONAL SAMPLE RESULTS FROM THE SAO PAULO SSAPP COHORT (2018) (0)
Application of Lipidomics in Psychiatry: Plasma-Based Potential Biomarkers in Schizophrenia and Bipolar Disorder (2023) (0)
Protein levels of APP, ADAM10 and BACE1 in aging adults with Down syndrome: Preliminary findings (2020) (0)
Society of biological psychiatry (1994) (0)
Poster #T231 ANTI-PSYCHOTIC TREATMENT DECREASED IPLA2 ACTIVITY IN FIRST EPISODE DRUG NAIVE PATIENTS (2014) (0)
Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease (2012) (0)
' s response to reviews Title : Pre-dementia in Alzheimer ' s disease (2010) (0)
CSF brain-derived neurotrophic factor (BDNF) is reduced in preclinical Alzheimer's disease (2010) (0)
Poster #M23 ANTIPSYCHOTIC TREATMENT DECREASED IPLA2 ACTIVITY IN FIRST EPISODE DRUG NAÏVE PATIENTS WITH SCHIZOPHRENIA (2014) (0)
Translation and validation of the Structured Interview for Prodromal Syndromes (SIPS) to Portuguese (2021) (0)
Poster #M20 INCREASED GLYCOGEN SYNTHASE KINASE-3B (GSK-3B) EXPRESSION IN PLATELETS OF FIRST ONSET PSYCHOSIS NON-AFFECTIVE PATIENTS (2014) (0)
Treatment of negative symptoms of schizophrenia with transcranial direct current stimulation (tDCS): clinical, randomized, sham-controlled, double-blind Researchers: (2019) (0)
PLASMATIC METABOLITES PREDICT CONVERSION FROM MILD COGNITIVE IMPAIRMENT TO ALZHEIMER’S DISEASE (2017) (0)
Poster #S139 PLA2 GENE EXPRESSION IN FIRST EPISODE DRUG NAIVE PATIENTS (2014) (0)
Phospholipase A2 inhibition in the rat hippocampus disrupts short- and long-term memory processing (2004) (0)
Inibição da fosfolipase 'A IND. 2' e hiperfosforilação da proteína Tau em culturas primárias de neurônios corticais e hipocampais (2007) (0)
30 anos da Revista de Psiquiatria Clínica (2003) (0)
Atividade de subtipos de 'PLA IND. 2' em neurônios primários mantidos em cultura (2007) (0)
GSK3beta em plaquetas de indivíduos com doença de Alzheimer e comprometimento cognitivo leve (2007) (0)
Tardive dyskinesia: preclinical and clinical aspects (2005) (0)
O aprendizado e a evocação de uma tarefa contextual aumentam atividade da fosfolipase 'A IND.2' no córtex parietal associativo de ratos (2007) (0)
Motor Disorders in Alzheimer?s Disease and Mild Cognitive Impairment (2007) (0)
P3-340: PLA2 enzyme: New target for memantine action (2008) (0)
Da arte de fazer ciência e de comer jabuticabas - uma homenagem ao Prof. Dr. Ricardo Renzo Brentani (2012) (0)
Brasileiros estudam prevenção contra Alzheimer (1999) (0)
Alterações no Corpo Editorial da RPC (2006) (0)
Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer’s disease: A mass spectrometry study (2020) (0)
Platelet PLA2 activity in patients with mild cognitive impairment: a longitudinal study (2011) (0)
Social-economic profile of a Brazilian frailty elderly sample (2011) (0)
Looking back on a prosperous year 2014 (2014) (0)
LOW DOSES OF LITHIUM CHANGE PKA, AKT AND TAU PROTEIN IN CORTICAL AND HIPPOCAMPAL NEURONS CELL CULTURE (2014) (0)
A liberdade cura? Relato a proposito da "psiquiatria democratica" na Italia (1979) (0)
Authors' reply (2007) (0)
Disturbances in Motor Dexterity Performance as Predictor for Neuroleptic Extrapyramidal Side Effects in Schizophrenia (1992) (0)
Lithium increases mitochondrial function in cultured hippocampal neurons (2011) (0)
Effects of the Menstrual Cycle on the Therapeutic Response in Schizophrenia (1992) (0)
Molecular modeling and structural analysis of the Myelin basic protein-Q65ZS4. (2007) (0)
P4-167 Inhibition of phospholipase A2 in neurons: effects of neurite outgrowth and viability (2004) (0)
Use of a Bayesian Network Model to predict psychiatric illness in individuals with ‘at risk mental states’ from a general population cohort (2021) (0)
REM SLEEP REGULATION IN DEMENTIA OF THE ALZHEIMER TYPE AND OLD‐AGE DEPRESSION (1992) (0)
897. Association between Childhood Adversity and Ultra-High Risk for Psychosis Status in a Populational Sample of Sao Paulo, Brazil (2017) (0)
Contents of volume 250 · 2000 (2000) (0)
[HLA-system in psychiatric research (author's transl)]. (1981) (0)
Serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia: Failure to detect abnormalities (1992) (0)
SA61. Association Between Childhood Adversity and Ultra-High Risk for Psychosis Status in a Populational Sample of Sao Paulo, Brazil (2017) (0)
Assimilating knowledge from neuroimages in schizophrenia diagnostics (2008) (0)
Dr. Paul Janssen (1926-2003) (2003) (0)
EFFECT OF CHRONIC LITHIUM TREATMENT ON TELOMERIC LENGTH IN TRIPLE-TRANSGENIC ALZHEIMER'S DISEASE MICE (2016) (0)
Dopamine receptor D2 genetic polymorphism associated with transition to mental disorders in a cohort of individuals with at-risk mental state for psychosis. (2023) (0)
Membrane Abnormalities in Psychotic Disorders (2003) (0)
P.4.11 Specific alterations of brain membranes in schizophrenia (2004) (0)
Disturbances in motor dexterity performance of schizophrenic patients as predictor for the manifestation of extrapyramidal side effects during neuroleptic treatment (1992) (0)
P2-150: Inhibition of phospholipase A2 increases phosphorylation of tau in primary cultures of hippocampal neurons (2008) (0)
Front & Back Matter (2014) (0)
P3-126: Diagnostic properties of the short cognitive performance test in screening for mild cognitive impairment and Alzheimer's disease (2008) (0)
Spontaneous speech in Alzheimer type, multi-infarct, and depressive “pseudo”-dementia (1989) (0)
Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability (2020) (0)
Decreased PLA2‐activity in platelets of paraoxone poisoned mini pigs (1996) (0)
Treatment of depression in the elderly with repetitive transcranial magnetic stimulation using theta-burst stimulation: Study protocol for a randomized, double-blind, controlled trial (2022) (0)
Low doses of lithium increased intra- and extracellular brain-derived neurotrophic factor (BDNF) and tumor necrosis factor (TNF) α in cortical and hippocampal neuron cell culture (2013) (0)
[HLA, schizophrenias and arthropathies]. (1981) (0)
Corrigendum to “The detection of depression in medical setting: A study with PRIME-MD” [Journal of Affective Disorders 91/1 (2006) 11–17] (2006) (0)
Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia (2004) (0)
PROTEOMIC ANALYSIS OF HIPPOCAMPAL CELL CULTURE WITH LOW DOSES OF LITHIUM TREATMENT (2016) (0)
P3-124 The influence of lithium on the risk of Alzheimer's disease (2004) (0)
Long-term treatment with cholinesterase inhibitors restores homeostatic levels of calcium-independent PLA2: Evidence of disease-modification in Alzheimer's disease (2013) (0)
Regular physical activity in a healthy elderly population is associated with lower peripheral iPLA2 activity (2013) (0)
APOE-ε4 interaction with single-nucleotide polymorphisms and risk for Alzheimer's disease (2012) (0)
Increased Lysophosphatidylcholine in Platelet Membrane from Schizophrenics (1992) (0)
Search for the Causes of Schizophrenia - Vol 5 (2004) (0)
Platelet APP‐ratio correlates with CSF levels of Aβ1‐42 in Alzheimer’s disease patients (2020) (0)
P4-138 Cognitive impairment in the elderly with bipolar disorder - influence of language disturbances (2006) (0)
Author's reply (2011) (0)
Detecting At-Risk Mental States for Psychosis (ARMs) in General Population Individuals Using Machine Learning Ensembles and Facial Features (2022) (0)
Specific alterations of brain membranes in schizophrenia (2004) (0)
Polymorfism Of CYP2C9 And 3A5 and carbamazepine hypersensitivity reactions in Brazilian subjects (2014) (0)
Inhibition of PLA2 inactivates GSK3B via Akt and CAMKII in primary cultures of hippocampal neurons (2012) (0)
Effects of neuroleptic therapy on phospholipid metabolism in schizophrenia (1992) (0)
Treino de memória aumenta a atividade de 'PLA IND. 2' em plaquetas (2007) (0)
A radioenzymatic assay for the determination of phospholipase A2 in serum suitable for psychiatric and non-psychiatric patients. (1988) (0)
T51. TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH TRANSCRANIAL CURRENT STIMULATION (TDCS): RESULTS OF RANDOMIZED, DOUBLE-BLINDED, SHAM-CONTROLLED TRIAL (2018) (0)
Human leukocyte antigen genotype in antiepileptics hypersensitivity reactions: a pilot study in Brazilian patients (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Wagner Farid Gattaz?

Wagner Farid Gattaz is affiliated with the following schools:

Faculdade de Medicina do ABC
University of São Paulo